Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
The trypanosome cyanide-insensitive alternative oxidase (TAO) and trypanosome glycerol kinase (TGK) are drug targets for human African sleeping sickness. In this study, I determined the crystal structures of TAO and TGK in complex with its lead compounds to make more potent drug. The crystal structure of TAO in complex with its new inhibitor, ferulenol was determined at 2.7 Å resolution. I found GK-17b which is a novel inhibitor of TGK. In addition, this compound inhibits TAO enzymatic activity with comparable strength.
|